These results suggest that ROR1-dependent invasion signaling is blocked by binding of the DKK1/CS-E complex to ROR1 and that DKK1 exerts anti-tumorigenic effects by blocking the tumor invasion activity of CS-E as well as by inhibiting β-catenin-dependent Wnt signaling. This evidence concerns the gene ROR1 and neoplasm.